BCLPX
Price
$8.59
Change
-$0.00 (-0.00%)
Updated
Dec 12 closing price
Net Assets
4.7B
DAMDX
Price
$27.17
Change
+$0.01 (+0.04%)
Updated
Dec 12 closing price
Net Assets
269.62M
Interact to see
Advertisement

BCLPX vs DAMDX

Header iconBCLPX vs DAMDX Comparison
Open Charts BCLPX vs DAMDXBanner chart's image
BlackRock Event Driven Equity Inv C
Price$8.59
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.7B
Dunham Monthly Distribution A
Price$27.17
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets269.62M
BCLPX vs DAMDX Comparison Chart in %
View a ticker or compare two or three
VS
BCLPX vs. DAMDX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCLPX is a Buy and DAMDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCLPX has more cash in the bank: 4.7B vs. DAMDX (270M). DAMDX pays higher dividends than BCLPX: DAMDX (7.90) vs BCLPX (3.47). BCLPX was incepted earlier than DAMDX: BCLPX (18 years) vs DAMDX (17 years). DAMDX (2.63) is less costly to investors than BCLPX (2.36). DAMDX is a more actively managed with annual turnover of: 209.00 vs. BCLPX (81.00). BCLPX has a lower initial minimum investment than DAMDX: BCLPX (1000) vs DAMDX (5000). DAMDX annual gain was more profitable for investors over the last year : 8.01 vs. BCLPX (5.16). DAMDX return over 5 years is better than : 8.91 vs. BCLPX (7.52).
BCLPXDAMDXBCLPX / DAMDX
Total Expense Ratio2.272.6386%
Annual Report Gross Expense Ratio2.362.6390%
Fund Existence18 years17 years-
Gain YTD6.1546.93289%
Front LoadN/A6%-
Min. Initial Investment1000500020%
Min. Initial Investment IRAN/AN/A-
Net Assets4.7B270M1,739%
Annual Yield % from dividends3.477.9044%
Returns for 1 year5.168.0164%
Returns for 3 years9.4617.7353%
Returns for 5 years7.528.9184%
Returns for 10 years21.840.942,313%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEQAX10.420.08
+0.77%
Oaktree Emerging Markets Equity A
AHSZX23.370.10
+0.43%
Alger Health Sciences Z
CAAPX43.84N/A
N/A
Ariel Appreciation Investor
ACIHX71.98-0.11
-0.15%
American Century Growth G
GAGPX11.21-0.04
-0.36%
Goldman Sachs Em Mkts Eq Insghts P